VFY · ASX

Vitrafy Life Sciences Ltd. (ASX:VFY)

AU$1.6

 -0.005 (-0.313%)
ASX:Live
18/08/2025 10:09:22 AM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

VFY Overview

VFY Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About VFY

Website

N/A

Telephone

Address

Description

N/A

VFY Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.08 - 2.1

Trade Value (12mth)

AU$12,362.00

1 week

0%

1 month

6.67%

YTD

-8.57%

1 year

0%

All time high

2.10

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Next Company Report Date

11-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

VFY Announcements

Latest Announcements

Date Announcements

05 August 25

FY25 Full Year Results Presentation - Amended

×

FY25 Full Year Results Presentation - Amended

05 August 25

FY25 Corporate Governance Statement

×

FY25 Corporate Governance Statement

05 August 25

FY25 Appendix 4G

×

FY25 Appendix 4G

05 August 25

FY25 Full Year Results Presentation

×

FY25 Full Year Results Presentation

05 August 25

FY25 Appendix 4E and Annual Report

×

FY25 Appendix 4E and Annual Report

05 August 25

Leadership Transition at Vitrafy

×

Leadership Transition at Vitrafy

31 July 25

Expiry of Voluntary Escrow Restrictions

×

Expiry of Voluntary Escrow Restrictions

30 July 25

Q4 FY25 Quarterly Activities Report and Appendix 4C

×

Q4 FY25 Quarterly Activities Report and Appendix 4C

29 July 25

Appendix 4C, FY25 Annual Results and Investor Call Schedule

×

Appendix 4C, FY25 Annual Results and Investor Call Schedule

25 June 25

Notification of cessation of securities - VFY

×

Notification of cessation of securities - VFY

30 May 25

Change of Address

×

Change of Address

15 May 25

Application for quotation of securities - VFY

×

Application for quotation of securities - VFY

02 May 25

Vitrafy Q3 FY25 Investor Presentation

×

Vitrafy Q3 FY25 Investor Presentation

02 May 25

Release of Securities from Mandatory Escrow

×

Release of Securities from Mandatory Escrow

29 April 25

Q3 FY25 Quarterly Activities Report and Appendix 4C

×

Q3 FY25 Quarterly Activities Report and Appendix 4C

28 April 25

Vitrafy Q3 FY25 Investor Briefing

×

Vitrafy Q3 FY25 Investor Briefing

16 April 25

USAISR successful Phase 1 Blood Platelet study

×

USAISR successful Phase 1 Blood Platelet study

15 April 25

Notification regarding unquoted securities - VFY

×

Notification regarding unquoted securities - VFY

08 April 25

Application for quotation of securities - VFY

×

Application for quotation of securities - VFY

27 March 25

Release of Securities from Mandatory Escrow

×

Release of Securities from Mandatory Escrow

20 March 25

NWR Virtual Healthcare Conference Presentation

×

NWR Virtual Healthcare Conference Presentation

19 March 25

Vitrafy to present at NWR Virtual Healthcare Conference

×

Vitrafy to present at NWR Virtual Healthcare Conference

19 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

18 March 25

Vitrafy Awarded Industry Growth Program Grant

×

Vitrafy Awarded Industry Growth Program Grant

28 February 25

Notification of cessation of securities - VFY

×

Notification of cessation of securities - VFY

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

VFY Shortsell

Frequently Asked Questions

The current share price of Vitrafy Life Sciences Ltd. (VFY:ASX) is AU$1.6.
The 52-week high share price for Vitrafy Life Sciences Ltd. (VFY:ASX) is AU$2.10.
The 52-week low share price for Vitrafy Life Sciences Ltd. (VFY:ASX)? is AU$1.08.
Vitrafy Life Sciences Ltd. (VFY:ASX) does not pay a dividend.
Vitrafy Life Sciences Ltd. (VFY:ASX) does not pay a dividend.
Vitrafy Life Sciences Ltd. (VFY:ASX) has a franking level of 0.0%.
Vitrafy Life Sciences Ltd. (VFY:ASX) is classified in the Healthcare.
The current share price of Vitrafy Life Sciences Ltd. (VFY:ASX) is AU$1.6.
The 52-week high share price for Vitrafy Life Sciences Ltd. (VFY:ASX) is AU$2.10.
The 52-week low share price for Vitrafy Life Sciences Ltd. (VFY:ASX)? is AU$1.08.
Vitrafy Life Sciences Ltd. (VFY:ASX) does not pay a dividend.
Vitrafy Life Sciences Ltd. (VFY:ASX) does not pay a dividend.
Vitrafy Life Sciences Ltd. (VFY:ASX) has a franking level of 0.0%.
Vitrafy Life Sciences Ltd. (VFY:ASX) is classified in the Healthcare.